9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Hoffmann-La Roche
Adela, Inc
Massive Bio, Inc.
Incyte Corporation
AVM Biotechnology Inc
Trishula Therapeutics, Inc.
Tempus AI
Intensity Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Taproot Health
Vector Vitale LLC
Sanguine Biosciences
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Fate Therapeutics
Hoffmann-La Roche
Fate Therapeutics
Genzada Pharmaceuticals USA, Inc.
Blue Note Therapeutics
AstraZeneca
Tocagen Inc.
Shenzhen BinDeBio Ltd.
sigma-tau i.f.r. S.p.A.
Incyte Corporation
Celgene
INSYS Therapeutics Inc
Novacea